These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 32368817)

  • 1. Association between dihydrotestosterone and long-term risk for prostate cancer mortality: A prospective cohort study.
    Lundgren PO; Kjellman A; Norming U; Gustafsson O
    Prostate; 2020 Jul; 80(10):777-781. PubMed ID: 32368817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydrotestosterone levels and survival in screening-detected prostate cancer: a 15-yr follow-up study.
    Kjellman A; Akre O; Norming U; Törnblom M; Gustafsson O
    Eur Urol; 2008 Jan; 53(1):106-11. PubMed ID: 17482753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydrotestosterone and testosterone levels in men screened for prostate cancer: a study of a randomized population.
    Gustafsson O; Norming U; Gustafsson S; Eneroth P; Aström G; Nyman CR
    Br J Urol; 1996 Mar; 77(3):433-40. PubMed ID: 8814852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trial.
    Idan A; Griffiths KA; Harwood DT; Seibel MJ; Turner L; Conway AJ; Handelsman DJ
    Ann Intern Med; 2010 Nov; 153(10):621-32. PubMed ID: 21079217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of sex hormone levels and risk of prostate cancer.
    Gann PH; Hennekens CH; Ma J; Longcope C; Stampfer MJ
    J Natl Cancer Inst; 1996 Aug; 88(16):1118-26. PubMed ID: 8757191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway.
    Vatten LJ; Ursin G; Ross RK; Stanczyk FZ; Lobo RA; Harvei S; Jellum E
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):967-9. PubMed ID: 9367072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men.
    Kjaer TN; Ornstrup MJ; Poulsen MM; Jørgensen JO; Hougaard DM; Cohen AS; Neghabat S; Richelsen B; Pedersen SB
    Prostate; 2015 Sep; 75(12):1255-63. PubMed ID: 25939591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term radical prostatectomy outcomes among participants from the European Randomized Study of Screening for Prostate Cancer (ERSPC) Rotterdam.
    Loeb S; Zhu X; Schroder FH; Roobol MJ
    BJU Int; 2012 Dec; 110(11):1678-83. PubMed ID: 22998182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant association between serum dihydrotestosterone level and prostate volume among Taiwanese men aged 40-79 years.
    Liao CH; Li HY; Chung SD; Chiang HS; Yu HJ
    Aging Male; 2012 Mar; 15(1):28-33. PubMed ID: 21247242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
    Stanczyk FZ; Azen CG; Pike MC
    J Steroid Biochem Mol Biol; 2013 Nov; 138():10-6. PubMed ID: 23474436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum androgens: associations with prostate cancer risk and hair patterning.
    Demark-Wahnefried W; Lesko SM; Conaway MR; Robertson CN; Clark RV; Lobaugh B; Mathias BJ; Strigo TS; Paulson DF
    J Androl; 1997; 18(5):495-500. PubMed ID: 9349747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy Men.
    Sjoberg DD; Vickers AJ; Assel M; Dahlin A; Poon BY; Ulmert D; Lilja H
    Eur Urol; 2018 Jun; 73(6):941-948. PubMed ID: 29519548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer.
    Rittmaster R; Hahn RG; Ray P; Shannon JB; Wurzel R
    Urology; 2008 Oct; 72(4):808-12. PubMed ID: 18718641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NADiA ProsVue prostate-specific antigen slope, CAPRA-S, and prostate cancer--specific survival after radical prostatectomy.
    Moul JW; Sarno MJ; McDermed JE; Triebell MT; Reynolds MA
    Urology; 2014 Dec; 84(6):1427-32. PubMed ID: 25432832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Obesity-Related Hemodilution of Prostate-Specific Antigen, Dihydrotestosterone, and Testosterone.
    Klaassen Z; Howard LE; Moreira DM; Andriole GL; Terris MK; Freedland SJ
    Prostate; 2017 Apr; 77(5):466-470. PubMed ID: 27990661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher Dihydrotestosterone Is Associated with the Incidence of Lung Cancer in Older Men.
    Chan YX; Alfonso H; Chubb SA; Handelsman DJ; Fegan PG; Hankey GJ; Golledge J; Flicker L; Yeap BB
    Horm Cancer; 2017 Apr; 8(2):119-126. PubMed ID: 28233278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In older men an optimal plasma testosterone is associated with reduced all-cause mortality and higher dihydrotestosterone with reduced ischemic heart disease mortality, while estradiol levels do not predict mortality.
    Yeap BB; Alfonso H; Chubb SA; Handelsman DJ; Hankey GJ; Almeida OP; Golledge J; Norman PE; Flicker L
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E9-18. PubMed ID: 24257908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum glucose, triglycerides, and cholesterol in relation to prostate cancer death in the Swedish AMORIS study.
    Arthur R; Møller H; Garmo H; Häggström C; Holmberg L; Stattin P; Malmström H; Lambe M; Hammar N; Walldius G; Robinson D; Jungner I; Van Hemelrijck M
    Cancer Causes Control; 2019 Feb; 30(2):195-206. PubMed ID: 30421156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study.
    Pettersson A; Robinson D; Garmo H; Holmberg L; Stattin P
    Ann Oncol; 2018 Feb; 29(2):377-385. PubMed ID: 29161337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone, Dihydrotestosterone, Sex Hormone-Binding Globulin, and Incident Diabetes Among Older Men: The Cardiovascular Health Study.
    Joyce KE; Biggs ML; Djoussé L; Ix JH; Kizer JR; Siscovick DS; Shores MM; Matsumoto AM; Mukamal KJ
    J Clin Endocrinol Metab; 2017 Jan; 102(1):33-39. PubMed ID: 27732332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.